Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

Abroad (travel likely)Recruiting

Conditions

Glioma · Glioneuronal Tumor · Choroid Plexus Tumor · Pineal Tumors · Germ Cell Tumor · Tumor of the Sellar Region · Diffuse Midline Glioma, H3 K27M-Mutant · Ependymoma · Embryonal Tumor · Pineal Tumor · Hemangiopericytoma · Hemangioblastoma · Melanocytic Tumor of CNS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Innsbruck Universitaetsklinik, Innsbruck, Austria

  • Universitaetsklinikum Wien - AKH unikliniken, Vienna, Austria

  • Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium

  • Institut Jules Bordet, Anderlecht, Belgium

  • Universitair Ziekenhuis Brussel, Brussels, Belgium

  • C.H.U. Sart-Tilman, Liège, Belgium

  • AZ Delta - Campus Rumbeke, Roeselare, Belgium

  • CHU Lyon - Hopital neurologique Pierre Wertheimer, Lyon, France

  • Hopital de La Timone, Marseille, France

  • Hopital la Pitie-Salpetriere, Paris, France

  • Knappschaft Krankenhaus Langendreer, Bochum, Germany

  • Universitaetsklinikum Bonn, Bonn, Germany

  • Universitaetsklinikum Koeln, Cologne, Germany

  • Universitaetsklinikum - Essen, Essen, Germany

  • University Hospital Frankfurt -Senckenberg Institute of Neurooncology, Frankfurt, Germany

  • Universitaetsklinikum Jena, Jena, Germany

  • Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie, Leipzig, Germany

  • Universitaetsklinikum Regensburg, Regensburg, Germany

  • Diagnostic & Therapeutic Center of Athens Hygeia Hospital S.A., Athens, Greece

  • Ospedale Bellaria-Bologna, Bologna, Italy

  • Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

  • Istituto Neurologico Carlo Besta, Milan, Italy

  • IRCCS Ospedale San Raffaele, Milan, Italy

  • Istituto Oncologico Veneto, Padova, Italy

  • IRCCS-Regina Elena National Cancer Center, Roma, Italy

  • Ospedale San Giovanni - Dipartimento Neuroscienze, Torino, Italy

  • The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands

  • Leiden University Medical Centre, Leiden, Netherlands

  • Erasmus MC, Rotterdam, Netherlands

  • Oslo University Hospital - Radiumhospitalet, Oslo, Norway

  • Centro Hospitalar Universitario Lisboa Norte - Hospital Sta. Maria, Lisbon, Portugal

  • Instituto Portugues de Oncologia de Lisboa Francisco Gentil - EPE, Lisbon, Portugal

  • Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • Hospital De La Santa Creu I Sant Pau, Barcelona, Spain

  • Hospital Germans Trias i Pujol (Institut Catala D'Oncologia), Barcelona, Spain

  • Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain

  • Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  • UniversitaetsSpital Zurich - Neurology Clinic, Zurich, Switzerland

  • NHS Lothian - The Royal Infirmary Of Edinburgh, Edinburgh, United Kingdom

  • Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care, Newcastle upon Tyne, United Kingdom

  • Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, United Kingdom

Study leads
  • Michael Weller

    Principal Investigator

    EORTC Study Coordinator